This bill establishes a federal grant program to fund mobile vaccination units in states, directly affecting state health departments and local communities. It authorizes the Secretary to award grants for states to establish or expand mobile units that provide recommended childhood, adolescent, and adult immunizations, covering vehicle acquisition, equipment, and vaccine costs. States must submit applications and use funds solely for these mobile units, with the Secretary required to report on the program's effectiveness to Congress by September 2027. The program is funded for fiscal year 2027 with no specified budget amount.
This bill requires the Health and Human Services (HHS) Secretary to update all HHS grant program regulations and guidance related to opioid misuse to include *all* FDA-approved opioid overdose reversal drugs - not just naloxone. It specifically targets two key grant programs: the State Opioid Response Grants (under the 21st Century Cures Act) and the Tribal Opioid Response Grants, plus the Public Health Service Act's grant program for regional/national substance use disorder prevention. HHS must update existing references within one year of the bill's enactment to ensure grants cover any approved reversal drug. This directly affects states, tribes, and community organizations receiving these federal grants for opioid response programs.
The PASTEUR Act of 2026 creates a new government contracting program to incentivize development of new antimicrobial drugs for treating drug-resistant infections. The Health and Human Services Secretary would award contracts to pharmaceutical sponsors meeting specific criteria on clinical benefits, innovation, and public health impact, with annual payments ranging from $75 million to $300 million (adjusted for inflation). Contract requirements include ensuring drug availability, tracking resistance data, promoting appropriate use, and maintaining supply chains. The bill also establishes antimicrobial stewardship programs for hospitals and outpatient facilities and improves surveillance of antimicrobial use and resistance. This legislation aims to address antibiotic resistance by creating financial incentives for new treatments and improving how antimicrobials are used and monitored.
The Ensuring Access to General Surgery Act of 2026 directs the Health Resources and Services Administration to study how to better identify areas with insufficient general surgeons, particularly in rural and underserved communities. The study will evaluate current shortage designations and test a new methodology using hospital service areas and surgeon-to-population ratios to set accurate thresholds for shortage levels (e.g., critical shortage, adequate supply). Within one year, the Secretary must submit a report to Congress and publish data on surgeon availability, with annual updates to any designated shortage areas. This process aims to improve the accuracy of shortage identification to inform future resource allocation for surgical care access.
Treat and Reduce Obesity Act of 2025 This bill expands Medicare coverage of intensive behavioral therapy for obesity. Specifically, the bill allows coverage for therapy that is provided by (1) a physician who is not a primary care physician; or (2) other health care providers (e.g., physician assistants and nurse practitioners) and approved counseling programs, if provided upon a referral from, and in coordination with, a physician or primary care practitioner. Currently, such therapy is covered only if provided by a primary care practitioner. The bill also allows coverage under Medicare's prescription drug benefit of drugs used for the treatment of obesity or for weight loss management for individuals who are overweight.
This bill creates a new federal grant program to fund peer support services for family caregivers under the Older Americans Act. It provides $10 million annually (2026-2030) to states, nonprofits, tribes, and community organizations to develop in-person and virtual programs where trained caregivers help others navigate systems, share emotional support, and access resources. The program specifically prioritizes underserved groups including low-income communities, immigrants, LGBTQ+ caregivers, young caregivers under 35, and those with disabilities. Funds can also support workforce training for peer specialists and language access services like translation for non-English speakers or American Sign Language users.
This bill expands Medicare coverage for home infusion therapy by changing how external infusion pumps and certain non-self-administered drugs are treated as durable medical equipment. It requires that these items be covered if three conditions are met: the drug's FDA-approved instructions require professional supervision, a qualified home infusion supplier administers/supervises the therapy at home, and the drug requires at least 12 infusions annually (either IV/subcutaneous or at pump-requiring rates). The bill directly affects Medicare beneficiaries needing long-term infusion drugs and qualified home infusion therapy suppliers. It also mandates that Medicare notify patients about cost-sharing differences between home infusion therapy and other care settings. This policy change clarifies coverage for specific home-based infusion treatments under defined safety and frequency requirements.
This bill creates a pathway for Medicare to cover innovative medical devices earlier. It allows "breakthrough devices" (new technologies designated for expedited FDA review) to qualify for Medicare's "new technology add-on payment" if approved, cleared, or authorized by the FDA before July 1 of a fiscal year. This means Medicare beneficiaries gain faster access to these new devices, and hospitals receive additional payment for using them, effective in the first quarter after FDA approval. The provision applies to devices approved on or after July 1, 2023, and is designed to be budget-neutral.
This bill requires states to verify that Medicaid providers and suppliers are not deceased during enrollment and at least quarterly while enrolled. Starting January 1, 2027, states must check the federal Death Master File (a government database of deceased individuals) as part of provider onboarding and revalidation. The law directly affects all entities billing Medicaid for services, aiming to prevent fraud where deceased individuals' identities might be used. It creates a concrete, ongoing screening mechanism to ensure only active providers participate in the program.
This bill creates a federal grant program to help communities develop non-police mental health crisis response teams. It provides funding for local governments, clinics, fire departments, and nonprofits to recruit behavioral health professionals, establish co-response teams (combining mental health clinicians with emergency responders), and integrate these teams into 911 or 988 dispatch systems. The grants specifically support replacing police as the primary responders for mental health crises with clinician-led mobile teams or emergency medical services, while respecting existing state laws on detention. Recipients must report on response outcomes, diversion rates (cases handled without police), and community feedback.
